How many biotech companies are in Vilnius?

Vilnius is the densest biotech cluster in the Baltics, hosting most of the directory's Lithuanian profiles. The exact count appears in the page header above and updates with each directory refresh.

What is the biggest biotech company in Vilnius?

Northway Biotech (the historical Biotechpharma site) is Vilnius's anchor biologics CDMO with cGMP manufacturing, mammalian and microbial development, and recognition as a 2025 CDMO Leadership Award winner. Thermo Fisher Vilnius (formerly Fermentas) is the largest molecular tools manufacturing operation. Both are anchored in the BIO CITY expansion area at Mokslininku 4.

What is BIO CITY Vilnius?

BIO CITY is Vilnius's biotech expansion campus, anchored by Northway's manufacturing footprint and designed to add scale capacity for biologics manufacturing, R&D, and clean-room infrastructure through 2026 and beyond. See the full BIO CITY brief for the buildout map.

What sectors are strongest in Vilnius biotech?

Vilnius is strongest in CDMO and contract manufacturing (Northway), molecular tools (Thermo Fisher), genomics platforms (Atrandi Biosciences, CasZyme), diagnostics, and life-science research infrastructure. The cluster combines EU regulatory standards with competitive operating costs.

City page

Vilnius biotech and pharma directory

Vilnius is the strongest biotech cluster in the Baltics. The city anchors Lithuanian biologics CDMO (Northway Biotech), molecular tools manufacturing (Thermo Fisher Vilnius — formerly Fermentas), genomics platforms (Atrandi Biosciences, CasZyme), diagnostics, and the BIO CITY expansion campus. This page lists every Vilnius-based biotech, pharma, CDMO, and diagnostics company in the directory, hand-reviewed against leadership sources, physical address, and regulatory certifications.

Evidence

Visible records21

Verified21

Categories13

Regulated sites8

Avg sources / record0.0

City view

Where does this city read strongest?

Tools (3), Research (3), and CDMO (2). Most visible records: Cureline Baltic, Froceth JSC, and Gensinta UAB.

City view

Which standards and public evidence are already visible?

GMP (5), GLP (3), ISO-13485 (2), and FDA-Inspected (1). Latest review: 24 April 2026. Review cycle: April 2026.

City view

Why does this city matter?

This page brings visible companies and infrastructure records into one practical view of Vilnius.

City view

Related market brief

What the BIO CITY biotechnology city in Vilnius is, how Northway Biotech operates as the 2026 anchor tenant, which capabilities are live at BIO CITY Vilnius today, and how the multi-phase biotech city build-out is progressing — with sources.

Open related brief

By category

Vilnius by category

Jump into a category page filtered to this country only.

Tools (3)Research (3)CDMO (2)Genomics (2)Infrastructure anchor (2)CRO (2)Diagnostics (1)Drug discovery (1)Manufacturing (1)Cluster (1)Therapeutics (1)

Full list

Vilnius biotech and pharma directory

21 city records currently match the active filter.

Vilnius translational and precision-medicine CRO offering human biospecimen procurement, preclinical study design, custom animal models, and bioanalytical laboratory services for Northeastern Europe.

Lead: Olga PotapovaFounder and Chief Executive Officer, Cureline Group
Scale: CRO service delivery

Vilnius advanced-therapy medicinal product (ATMP) manufacturer producing individualized somatic cell-therapy products from patients' own adipose-derived cells, covering anti-cancer vaccines, mesenchymal stem cell preparations, and T-cell therapies for multiple sclerosis.

Lead: Agne VaitkevicieneHead and Co-Founder
Scale: Individualized ATMP manufacturing

Vilnius synthetic biology startup developing a new-generation DNA synthesis technology based on molecular biology and photonics methods, operating from the Vilnius City Innovation Industrial Park (Northtown).

Lead: Benas MacijauskasChief Executive Officer
Scale: Synthetic biology tools R&D

Vilnius Stem Cell Research Center managing the Lithuanian Stem Cell and Regenerative Medicine Cluster, with a disclosed 27 million EUR investment plan at Northtown and a 3D bioprinting research axis under the Northway group.

Lead: Vladas Algirdas BumelisFounder and Chairman of the Board, Northway group
Scale: Research center and cluster operations

Vilnius 3D bioprinting company developing mesoscale bioprinting systems, vascularized tissue models, and personalized-medicine tools for regenerative and biomedical applications.

Lead: Vydmantas ŠakalysDirector
Scale: Bioprinting technology and tissue-model development platform

Vilnius molecular-diagnostics and genomics laboratory delivering NIPT, pharmacogenomics, cancer testing, sequencing services, and personalized research workflows from Lithuania.

Lead: Arūnas LeipusDirector
Scale: Clinical genomics and sequencing platform

Vilnius diagnostics and bioprocess supplier producing in-vitro diagnostic systems, cell-culture media, sera, and purification materials for research and industrial workflows.

Lead: Pavel KarabliovChief Executive Officer
Scale: Bioprocess and diagnostic-supply platform for research and industrial users

Vilnius pharmaceutical-development and testing platform combining formulation development, analytical services, quality control, and market-access support for complex European programs.

Lead: Edita Griniute-MistinieneFounder and Chief Executive Officer
Scale: Pharmaceutical development and quality-control platform

Vilnius computational-biology company building generative protein-design tools for enzyme engineering and biological product discovery.

Lead: Laurynas KarpusChief Executive Officer and Co-Founder
Scale: AI-enabled protein-discovery platform

Vilnius national research institute spanning materials science, photonics, chemistry, and applied life-science instrumentation.

Lead: Assoc. Prof. Dr. Rimantas RamanauskasGeneral Director
Scale: Large interdisciplinary research institute

Vilnius innovation-campus operator connecting Saulėtekis research institutions, spinouts, prototyping support, and commercialization services.

Lead: Laima BalčiūnėCEO
Scale: Saulėtekis innovation campus operator

Vilnius University flagship life-science campus integrating biochemistry, molecular biology, biotechnology, and training infrastructure.

Lead: Assoc. Prof. Dr. Eugenijus ButkusHead of Center
Scale: University life-science flagship campus

Vilnius medicines-control authority overseeing national approvals, GMP supervision, pharmacovigilance, and regulated market surveillance.

Lead: Dovilė MarcinkėDirector
Scale: National medicines-control authority

Vilnius supply node for Thermo Fisher's cell-culture and CTS input chain supporting Baltic biologics and advanced-therapy workflows.

Lead: Verification pendingVilnius site lead — under review
Scale: Global life-science supply node

Vilnius vault node securing GDP and ISO-compliant pharmaceutical storage and specialist transport across the Baltic intake layer.

Lead: Laurent BendavidPresident, World Courier
Scale: Baltic specialty logistics hub

Vilnius biotech ingredients and white-label manufacturing platform operating with an ISO-backed quality system and a cannabinoid-processing focus.

Lead: Marijus JarockisChief Executive Officer
Scale: Regional manufacturing and export platform

Vilnius process-equipment and laboratory-infrastructure supplier supporting Lithuanian biotech, pharma, and research facilities with controlled-environment and bioprocess systems.

Lead: Gediminas CekanauskasChief Executive Officer
Scale: Regional infrastructure supply

Vilnius CDMO campus retained in the registry as the historical Biotechpharma operating base within Northway's current biologics manufacturing network.

Lead: Vladas Algirdas BumelisCEO, Executive Chairman of the Board and Advisory Board
Scale: Commercial CDMO

Vilnius CRISPR enzyme-discovery and genome-editing company building programmable nuclease platforms, custom research programs, and translational partnerships from its Lithuanian R&D base.

Lead: Dr. Giedrius GasiūnasChief Executive Officer and Co-Founder
Scale: Molecular

Vilnius microfluidics company building single-cell analysis instruments, consumables, and workflow systems around its SPC and droplet technology platforms.

Lead: Juozas NainysChief Executive Officer and Co-Founder
Scale: Micro-scale

Vilnius biologics CDMO anchor combining mammalian and microbial process development, GMP manufacturing, and BIO CITY expansion capacity inside Lithuania's main biopharma cluster.

Lead: Vladas Algirdas BumelisCEO and Chairman of the Board
Scale: Commercial CDMO

FAQ

Frequently asked questions

How many biotech companies are in Vilnius?: Vilnius is the densest biotech cluster in the Baltics, hosting most of the directory's Lithuanian profiles. The exact count appears in the page header above and updates with each directory refresh.
What is the biggest biotech company in Vilnius?: Northway Biotech (the historical Biotechpharma site) is Vilnius's anchor biologics CDMO with cGMP manufacturing, mammalian and microbial development, and recognition as a 2025 CDMO Leadership Award winner. Thermo Fisher Vilnius (formerly Fermentas) is the largest molecular tools manufacturing operation. Both are anchored in the BIO CITY expansion area at Mokslininku 4.
What is BIO CITY Vilnius?: BIO CITY is Vilnius's biotech expansion campus, anchored by Northway's manufacturing footprint and designed to add scale capacity for biologics manufacturing, R&D, and clean-room infrastructure through 2026 and beyond. See the full BIO CITY brief for the buildout map.
What sectors are strongest in Vilnius biotech?: Vilnius is strongest in CDMO and contract manufacturing (Northway), molecular tools (Thermo Fisher), genomics platforms (Atrandi Biosciences, CasZyme), diagnostics, and life-science research infrastructure. The cluster combines EU regulatory standards with competitive operating costs.

Related briefs

Briefs that mention Vilnius

Market brief

Baltic CRO & Clinical Trial Landscape 2026: Lithuania, Latvia, Estonia

A practical map of the Baltic clinical research organisation landscape — Biomapas, Cureline Baltic, Inpharmatis, Asper Biogene, BioCC — and why Lithuania, Latvia, and Estonia are a credible nearshore option for EU-regulated clinical trials in 2026.

Open brief

Market brief

Viral Vector CDMO Europe 2026: AAV, Adenovirus, Lentivirus

Where to manufacture viral vectors in Europe in 2026 — FinVector, Kuopio Center for Gene and Cell Therapy, 3PBIOVIAN, Fuse Vectors, IDT Biologika — and how the European viral vector CDMO layer is structured.

Open brief

Market brief

Baltic Biotech Landscape 2026: Lithuania, Latvia, Estonia

A practical map of the Baltic biotech and pharma landscape in 2026 — 74 operators across Lithuania, Latvia, and Estonia, organised by city, category, and what each actually does in the European supply chain.

Open brief

Next step

Read the city, then widen the view.

Use country and regional pages for wider context, and the company suggestion form for new candidate records.

Open country page Open regional page Suggest a company

Vilnius biotech and pharma directory

Where does this city read strongest?

Which standards and public evidence are already visible?

Why does this city matter?

Related market brief

Vilnius by category

Vilnius biotech and pharma directory

Cureline Baltic

Froceth JSC

Gensinta UAB

Stem Cell Research Center (SCRC)

Vital3D Technologies

Saidė Genomics

LT Biotech

Profarma

Biomatter

Center for Physical Sciences and Technology

Sunrise Tech Park

Vilnius University Life Sciences Center

State Medicines Control Agency Lithuania

Thermo Fisher Supply Vilnius

World Courier Baltics

Sanobiotec

Biotecha

Biotechpharma (Northway)

CasZyme

Atrandi Biosciences

Northway Biotech

Frequently asked questions

Briefs that mention Vilnius

Baltic CRO & Clinical Trial Landscape 2026: Lithuania, Latvia, Estonia

Viral Vector CDMO Europe 2026: AAV, Adenovirus, Lentivirus

Baltic Biotech Landscape 2026: Lithuania, Latvia, Estonia

Read the city, then widen the view.